Maraviroc in Immunological Non-Responder (INR) HIV-1-infected Subjects

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Stefano Rusconi, Ospedale L. Sacco - Polo Universitario
ClinicalTrials.gov Identifier:
NCT00884858
First received: April 20, 2009
Last updated: April 29, 2013
Last verified: April 2013